Search

everythinglearnresearchcommunity

for

Search:↓

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Higher concentrations of dithranol can help regrow hair in severe alopecia areata.

This therapy effectively treats resistant alopecia areata with minimal side effects.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

People with Alopecia areata often have lower vitamin D levels, which may be linked to the severity of their condition.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.